ESRD From Autosomal Dominant Polycystic Kidney Disease in the United States, 2001-2010-Reference-Cited by-同舟云学术

ESRD From Autosomal Dominant Polycystic Kidney Disease in the United States, 2001-2010

Published:2014-10 Issue:4 Volume:64 Page:592-599
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Reule Scott,Sexton Donal J.,Solid Craig A.,Chen Shu-Cheng,Collins Allan J.,Foley Robert N.

Publisher

Elsevier BV

Subject

Nephrology

Reference13 articles.

1. US Renal Data System 2012 annual data report;Collins;Am J Kidney Dis,2013

2. Tolvaptan in autosomal dominant polycystic kidney disease;Jouret;N Engl J Med,2013

3. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease;Hogan;J Am Soc Nephrol,2010

4. Rapamycin for treatment of type I autosomal dominant polycystic kidney disease (RAPYD-study): a randomized, controlled study;Stallone;Nephrol Dial Transplant,2012

5. US Renal Data System. 2013 Researcher's guide to the USRDS database; appendix D: data file descriptions. http://www.usrds.org/2013/rg/C_Data_File_Descriptions_13.pdf. Accessed May 20, 2014.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. People with genetic kidney diseases on kidney replacement therapy have different clinical outcomes compared to people with other kidney diseases;Scientific Reports;2024-03-21

2. Mortality risk in patients with autosomal dominant polycystic kidney disease;BMC Nephrology;2024-02-16

3. Autosomal Dominant Polycystic Kidney Disease: Epidemiological, Clinical Aspects and Predictive Factors of Poor Renal Prognosis (About 300 Cases);Open Journal of Nephrology;2024

4. Advances in the management of chronic kidney disease;BMJ;2023-12-05

5. Predicting autosomal dominant polycystic kidney disease progression: review of promising Serum and urine biomarkers;Frontiers in Pediatrics;2023-11-10